The co-founder and CEO of Kaligia Bioscience, Fazal Fazlin, spoke with ABC News regarding the partnership with AdventHealth, the USF College of Pharmacy, the USF College of Medicine and Tampa General Hospital to collect positive and negative COVID-19 saliva samples for the expedited development of new COVID-19 tests.

Speaking about the objectives of the new tests for the patients, Fazal notes “I want them to say that this is accurate, this was easy, and this was quick. So people would not be afraid to get themselves tested for it,” said Fazlin.

Full Article at ABC Action News – Tampa Bay

Leave a Reply